Chemoradiation in Cancer Therapy Book

Part I. General/Background

Chemoradiation: Biological Principles and Perspectives

Hak Choy and Robert M. MacRae

Fluoropyrimidines as Radiation Sensitizers

Muhammad Wasif Saif and Robert B. Diasio

Part II. Mechanisms of Interaction of Specific Chemotherapeutic Agents with Radiation

The Role of Platinum Complexes in Combined Modality Therapy

Beverly A. Teicher

Taxanes in Combined Modality Therapy

Robert M. MacRae and Hak Choy

Camptothecin Radiation Sensitization

Tyvin A. Rich

The Role of Gemcitabine in Combined Modality Therapy

Jerome Landry, William Blacksk, Robert M. MacRae, Gary Yang, and Hak Choy

Part III. Clinical Applications

Chemoradiation Strategies for Patients with Malignant Gliomas

Heather A. Curry and Walter J. Curran, Jr.

Combined Modality Strategies in the Treatment of Head and Neck Cancer

Cathy Eng and Everett E. Vokes

The Role of Combined Modality Therapy for Stage III Nonsmall-Cell Lung Cancer

Roger W. Byhardt

Combined Modality Treatment of Small-Cell Lung Cancer

Julie R. Brahmer, Larry Kleinberg, and David S. Ettinger

The Role of Chemoradiation in the Management of Esophageal Cancer

Arlene Forastiere and Bapsi Chak

Combined Modality Therapy in Locally Advanced Breast Cancer

Silvia C. Formenti and Matthew Volm

Combined Modality Therapy for Gastric, Pancreatic, and Biliary Tract Carcinomas

Alexandria Phan and Jaffer A. Ajani

Chemoradiation in Therapy for Colon and Rectum Carcinoma

Jason H. Lee and Christopher G. Willett

Chemoradiotherapy in Muscle-Invasive Bladder Cancer

Bruce J. Roth

The Role of Combined Chemotherapy and Radiation Therapy in the Treatment of Gynecologic Malignancies

Patricia J. Eifel

Part IV. Specific Molecular Targeted Agents

Overview of Specific Molecular Targeted Agents for Combined Modality Therapy

Scott Saxman and Janet Dancey

Receptor Tyrosine Kinases as Therapeutic Targets in Solid Tumors

Stacy L. Moulder and Carlos L. Arteaga

Adenoviral p53 Gene Therapy Strategies in Nonsmall-Cell Lung Cancer

Stephen G. Swisher and Jack A. Roth

Tumor Microvasculature as a Therapeutic Target During Radiotherapy

Dennis E. Hallahan and Don Stacy

Cancer Drug Discovery and Development: Maximizing the Therapeutic Potential of Matrix Metalloproteinase Inhibitors for the Treatment of Cancer

Jeffrey S. Humphrey, Karen Price, Elora Gupta, Andrew Baxter, John Bird, Daryl Sonnichsen, and Joseph Naglich

The Role of Cyclooxygenase-2 Inhibitors in Combined Modality Therapy

Hong Pyo, Raymond N. DuBois, and Hak Choy

Index